Point72 (DIFC)’s Aclaris Therapeutics ACRS Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2025
Q2
Sell
-6,132
Closed -$9.38K 942
2025
Q1
$9.38K Buy
6,132
+2,424
+65% +$3.71K ﹤0.01% 771
2024
Q4
$9.2K Buy
3,708
+3,616
+3,930% +$8.97K ﹤0.01% 785
2024
Q3
$106 Sell
92
-18,227
-99% -$21K ﹤0.01% 845
2024
Q2
$20.2K Buy
+18,319
New +$20.2K ﹤0.01% 687